Organic Letters
Accession Codes
Letter
Phosphine-catalyzed asymmetric organic reactions. Chem. Rev. 2018,
118, 9344−9411. (e) Guo, H.; Fan, Y. C.; Sun, Z.; Wu, Y.; Kwon, O.
Phosphine organocatalysis. Chem. Rev. 2018, 118, 10049−10293.
(9) Vedejs, E.; Daugulis, O.; Diver, S. T. Enantioselective acylations
catalyzed by chiral phosphines. J. Org. Chem. 1996, 61, 430−431.
(10) (a) Gong, J.-J.; Li, T.-Z.; Pan, K.; Wu, X.-Y. Enantioselective
intramolecular Rauhut-Currier reaction catalyzed by chiral phosphi-
nothiourea. Chem. Commun. 2011, 47, 1491−1493. (b) Takizawa, S.;
Nguyen, T. M.-N.; Grossmann, A.; Enders, D.; Sasai, H.
Enantioselective synthesis of α-alkylidene-γ-butyrolactones: intra-
molecular rauhut-currier reaction promoted by acid/base organo-
catalysts. Angew. Chem., Int. Ed. 2012, 51, 5423−5426. (c) Su, X.;
Zhou, W.; Li, Y.; Zhang, J. Design, synthesis, and application of a
chiral sulfinamide phosphine catalyst for the enantioselective
intramolecular Rauhut−Currier reaction. Angew. Chem., Int. Ed.
2015, 54, 6874−6877. (d) Zhang, X.-Z.; Gan, K.-J.; Liu, X.-X.;
Deng, Y.-H.; Wang, F.-X.; Yu, K.-Y.; Zhang, J.; Fan, C.-A.
Enantioselective synthesis of functionalized 4-aryl hydrocoumarins
and 4-aryl hydroquinolin-2-ones via intramolecular vinylogous rauhut-
currier reaction of para-quinone methides. Org. Lett. 2017, 19, 3207−
3210. (e) Shi, Z.; Yu, P.; Loh, T.-P.; Zhong, G. Catalytic asymmetric
[4 + 2] annulation initiated by an aza-Rauhut−Currier reaction: facile
entry to highly functionalized tetrahydropyridines. Angew. Chem., Int.
Ed. 2012, 51, 7825−7829. (f) Dong, X.; Liang, L.; Li, E.; Huang, Y.
Highly enantioselective intermolecular cross Rauhut−Currier reaction
catalyzed by a multifunctional lewis base catalyst. Angew. Chem., Int.
Ed. 2015, 54, 1621−1624. (g) Zhou, W.; Su, X.; Tao, M.; Zhu, C.;
Zhao, Q.; Zhang, J. A novel chiral sulfinamide bisphosphine catalysts:
design, synthesis, and application in highly enantioselective inter-
molecular cross Rauhut−Currier reactions. Angew. Chem., Int. Ed.
2015, 54, 14853−14857. (h) Li, S.; Liu, Y.; Huang, B.; Zhou, T.; Tao,
H.; Xiao, Y.; Liu, L.; Zhang, J. Phosphine-catalyzed asymmetric
intermolecular cross vinylogous Rauhut-Currier reactions of vinyl
ketones with para-quinone methides. ACS Catal. 2017, 7, 2805−2809.
(11) (a) Shi, M.; Chen, L.-H.; Li, C.-Q. Chiral phosphine lewis bases
catalyzed asymmetric aza-baylis−hillman reaction of N-sulfonated
imines with activated olefins. J. Am. Chem. Soc. 2005, 127, 3790−
3800. (b) Song, H.-L.; Yuan, K.; Wu, X.-Y. Chiral phosphine-
squaramides as enantioselective catalysts for the intramolecular
Morita−Baylis−Hillman reaction. Chem. Commun. 2011, 47, 1012−
1014. (c) Takizawa, S.; Kiriyama, K.; Ieki, K.; Sasai, H. A bifunctional
spiro-type organocatalyst with high enantiocontrol: application to the
aza-morita−baylis−hillman reactions. Chem. Commun. 2011, 47,
9227−9229. (d) Gao, Y.; Xu, Q.; Shi, M. Enantioselective synthesis
of polycyclic indole derivatives based on aza-morita−baylis−hillman
reaction. ACS Catal. 2015, 5, 6608−6614. (e) Satpathi, B.;
Ramasastry, S. S. V. Angew. Chem., Int. Ed. 2016, 55, 1777−1781.
(12) (a) Smith, S. W.; Fu, G. C. Asymmetric carbon- carbon bond
formation y to a carbonyl group: phosphine-catalyzed addition of
nitromethane to allenes. J. Am. Chem. Soc. 2009, 131, 14231−14233.
(b) Zhong, F.; Dou, X.; Han, X.; Yao, W.; Zhu, Q.; Meng, Y.; Lu, Y.
Chiral phosphine catalyzed asymmetric Michael addition of oxindoles.
Angew. Chem., Int. Ed. 2013, 52, 943−947. (c) Wang, H.-Y.; Zhang,
K.; Zheng, C.-W.; Chai, Z.; Cao, D.-D.; Zhang, J.-X.; Zhao, G.
Asymmetric dual-reagent catalysis: mannich-type reactions catalyzed
by ion pair. Angew. Chem., Int. Ed. 2015, 54, 1775−1779. (d) Wang,
H.-Y.; Zheng, C.-W.; Chai, Z.; Zhang, J.-X.; Zhao, G. Asymmetric
cyanation of imines via dipeptide-derived organophosphine dual-
reagent catalysis. Nat. Commun. 2016, 7, 12720. (e) Huang, B.; Li, C.;
Wang, H.; Wang, C.; Liu, L.; Zhang, J. Phosphine-catalyzed diastereo-
and enantioselective Michael addition of β-carbonyl esters to β-
trifluoromethyl and β-ester enones: enhanced reactivity by inorganic
base. Org. Lett. 2017, 19, 5102−5105.
CCDC 1940604 contains the supplementary crystallographic
data for this paper. These data can be obtained free of charge
bridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
AUTHOR INFORMATION
■
Corresponding Author
ORCID
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work is supported by the Natural Science Foundation of
China (21572264 and 21871293) and the Chinese Universities
Scientific Fund (2018TC052, 2018TC055, and 2019TC085).
REFERENCES
■
(1) (a) Ardiansah, B. Recent reports on pyrazole-based bioactive
compounds as candidate for anticancer agents. Asian J. Pharm. Clin.
Res. 2017, 10, 45−51. (b) Arunachalam, S.; Gowrishankar, N. L.;
Krishnan, A.; Prakash, M.; Muhsin, T.; Naseena, U.; Poornima, G. A
brief review on pyrazole derivatives possesing variouspharmacological
and biological evaluation. World J. Pharm. Pharm. Sci. 2018, 7, 1496−
1503.
(2) (a) Ardiansah, B. Pharmaceutical importance of pyrazoline
derivatives: a mini review. J. Pharm. Sci. Res. 2017, 9, 1958−1960.
(b) Muralidharan, V.; Asha Deepti, C.; Raja, S. A Review on
Anticancer Potential of Substituted Pyrazoline Derivatives. Eur. J.
Biomed. Pharm. Sci. 2018, 5, 1−13.
(3) Faria, J. V.; Vegi, P. F.; Miguita, A. G. C.; dos Santos, M. S.;
Boechat, N.; Bernardino, A. M. R. Recently reported biological
activities of pyrazole compounds. Bioorg. Med. Chem. 2017, 25, 5891−
5903.
(4) For reviews, see: (a) Hanessian, S.; McNaughton-Smith, G.;
Lombart, H.-G.; Lubell, W. D. Design and synthesis of conforma-
tionally constrained amino acids as versatile scaffolds and peptide
mimetics. Tetrahedron 1997, 53, 12789−12854. (b) Konaklieva, M. I.;
Plotkin, B. J. Bioisosters of β-lactams as anti-infectives. Curr. Med.
Chem.: Anti-Infect. Agents 2003, 2, 287−302.
(5) (a) Watanabe, K.; Tanaka, M.; Yuki, S.; Hirai, M.; Yamamoto, Y.
How is edaravone effective against acute ischemic stroke and
amyotrophic lateral sclerosis. J. Clin. Biochem. Nutr. 2018, 62, 20−
38. (b) Raymer, B.; Bhattacharya, S. K. Lead-like Drugs: A
Perspective. J. Med. Chem. 2018, 61, 10375−10384.
(6) Gigante, A.; Tagarro, I. Non-Steroidal Anti-Inflammatory Drugs
and Gastroprotection with Proton Pump Inhibitors A Focus on
Ketoprofen/Omeprazole. Clin. Drug Invest. 2012, 32, 221−233.
(7) Nikolova, I.; Petkova, V.; Tencheva, J.; Benbasat, N.; Voinikov,
J.; Danchev, N. Metamizole: A Review Profile of a Well-Known
“Forgotten” Drug. Part II: Clinical Profile. Biotechnol. Biotechnol.
Equip. 2013, 27, 3605−3619.
(8) For selected reviews, see: (a) Xiao, Y.; Sun, Z.; Guo, H.; Kwon,
O. Chiral phosphines in nucleophilic organocatalysis. Beilstein J. Org.
Chem. 2014, 10, 2089−2121. (b) Xie, P. Z.; Huang, Y. Morita-Baylis-
Hillman adduct derivatives (MBHADs): versatile reactivity in Lewis
base-promoted annulation. Org. Biomol. Chem. 2015, 13, 8578−8595.
(c) Wang, T.; Han, X.; Zhong, F.; Yao, W.; Lu, Y. Amino acid-derived
bifunctional phosphines for enantioselective transformations. Acc.
Chem. Res. 2016, 49, 1369−1378. (d) Ni, H.; Chan, W.-L.; Lu, Y.
(13) (a) Mondal, M.; Ibrahim, A. A.; Wheeler, K. A.; Kerrigan, N. J.
Phosphine-catalyzed asymmetric synthesis of β-lactones from
arylketoketenes and aromatic aldehydes. Org. Lett. 2010, 12, 1664−
1667. (b) Chen, S.; Salo, E. C.; Wheeler, K. A.; Kerrigan, N.
Binaphane-catalyzed asymmetric synthesis of trans-β-lactams from
disubstituted ketenes and n-tosyl arylimines. Org. Lett. 2012, 14,
D
Org. Lett. XXXX, XXX, XXX−XXX